Sign In

Richard Gaster

Managing Partner at venBio Partners

Richard Gaster, M.D., Ph.D., is a prominent figure in the life sciences investment sector, currently serving as a Managing Partner at venBio Partners. His career encompasses extensive experience as a physician, entrepreneur, and investor in the life sciences field.

Professional Background

  • Education: Dr. Gaster graduated summa cum laude with a BSE in Bioengineering from the University of Pennsylvania. He then earned both his M.D. and Ph.D. in Bioengineering from Stanford University as part of the Medical Scientist Training Program.
  • Early Career: He began his medical career as a resident physician in Harvard’s Plastic and Reconstructive Surgery Program. Following this, he worked at Third Rock Ventures as a Senior Associate, where he played a crucial role in the formation and launch of Pliant Therapeutics.
  • venBio Partners: Dr. Gaster joined venBio in 2017 and has since been instrumental in launching and investing in several successful biopharmaceutical companies. His portfolio includes notable companies such as Akero Therapeutics, Harmony Biosciences, and Elevation Oncology, among others.124

Contributions and Achievements

  • Investment Strategy: At venBio, Dr. Gaster focuses on developing novel therapeutics for unmet medical needs, actively participating in strategic guidance for portfolio companies. Under his leadership, venBio has raised significant capital through various funds to support its investments.235
  • Board Memberships: He serves on the boards of several biotech firms including 35Pharma, Entact Bio, Attralus, and Arrakis Therapeutics.45 His involvement extends to providing oversight and strategic direction to these companies as they navigate clinical development and commercialization.

Recognition

Dr. Gaster's contributions to science and healthcare have been recognized widely; he has published numerous articles in prestigious journals and holds multiple patents related to his work.4 He was also named one of Forbes' “30 Under 30” in Science and Healthcare, highlighting his impact on the field at a relatively young age.

In summary, Richard Gaster is a key player in the life sciences investment landscape, leveraging his medical expertise and entrepreneurial spirit to drive innovation in therapeutics through his role at venBio Partners.

Highlights

Sep 22 · thenetwork.com
Richard Gaster - The Network
Mar 6 · signal.nfx.com
Richard Gaster's Investing Profile - venBio Managing Partner | Signal
Mar 6 · GlobeNewswire
Alumis Announces Upsized $259M Series C Financing to Advance Clinical-stage Pipeline of Oral Therapies Designed ... - GlobeNewswire
Alumis Announces Upsized $259M Series C Financing to Advance Clinical-stage Pipeline of Oral Therapi
Mar 6 · GlobeNewswire
Alumis Announces Upsized $259M Series C Financing to Advance Clinical-stage Pipeline of Oral Therapies Designed ... - GlobeNewswire
Alumis Announces Upsized $259M Series C Financing to Advance Clinical-stage Pipeline of Oral Therapi
Jan 1 · venbio.com
“venBio Raises $528 Million Venture Capital Fund Focused on Life ...
Jun 3 · businesswire.com
venBio Raises $550 Million Venture Capital Fund Focused on Life ...

Related Questions

What are some of the notable companies Richard Gaster has invested in?
How did Richard Gaster transition from being a physician to a venture capitalist?
What is venBio's investment strategy under Richard Gaster's leadership?
How has Richard Gaster's background in medicine influenced his investment decisions?
What are the key achievements of venBio under Richard Gaster's management?
Richard Gaster
Richard Gaster, photo 1
Richard Gaster, photo 2
Add to my network

Location

San Francisco, California, United States